Drawing for TULIP

USPTO serial 79231626

TULIP

Reviewed by CopyMark Law Group

Reg. 5969631Status 709
Filing date
Status date
Registration date
Jan 28, 2020
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TULIP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

E. Anthony Figg

E. Anthony Figg ROTHWELL FIGG ERNST & MANBECK PC901 New York Avenue, N.W.Suite 900 EastWashington, DC 20001

Goods and services

ClassDescriptionStatusFirst use
041Publication of journals, newsletters and scientific papers all featuring the results of clinical trials in the field of anticancer drugs; publication of journals, newsletters and scientific papers all featuring results of clinical trials for pharmaceutical preparationsSECTION 71 - CANCELLED—
042Performing clinical trials for others relating to pharmaceutical products in the field of anticancer drugs; providing medical and scientific research information on clinical trials in the field of anticancer medicines through an interactive website; providing medical and scientific research information in the field of pharmaceutical products and clinical trials in the field of anticancer drugs; conducting clinical trials for third parties in the field of anticancer drugs; conducting clinical trials for others; performing clinical trials for others in the field of pharmaceutical products; provision of information about the results of clinical trials for pharmaceutical products for scientific and medical research purposes; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing medical and scientific research information about clinical studies via an interactive website; all of the above services directed to pharmaceutical companiesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 14, 2026C71TCANCELLED SECTION 71—
Jan 28, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 21, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 21, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 21, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 11, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 29, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 9, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 8, 2020FIMPFINAL DISPOSITION PROCESSED—
Apr 28, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 12, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 8, 2019GPNXNOTIFICATION PROCESSED BY IB—
Nov 1, 2019OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 23, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 23, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 23, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 16, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 16, 2019OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 17, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 17, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 10, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 10, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 10, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 20, 2019RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 13, 2019ALIEASSIGNED TO LIE—
Nov 15, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 15, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Nov 15, 2018CNSLSUSPENSION LETTER WRITTEN—
Oct 25, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 24, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 24, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 24, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 21, 2018RFNTREFUSAL PROCESSED BY IB—
Jul 5, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 5, 2018RFRRREFUSAL PROCESSED BY MPU—
Jun 23, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 22, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2018DOCKASSIGNED TO EXAMINER—
May 22, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
May 19, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
May 15, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 10, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance